This inventor holds 1 USPTO granted patent. Top assignee: Agouron Pharmaceuticals, Inc.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Innovator in Pharmaceuticals: Anand Sistla
Introduction: Anand Sistla is a notable inventor based in Carlsbad, California, recognized for his contributions to the field of pharmaceuticals. With a keen focus on developing novel treatments for serious medical conditions, his work has garnered attention in the research community.
Latest Patents: Anand Sistla holds a patent for "Salts and polymorphs of a VEGF-R inhibitor," which relates to the innovative salts and free base forms of N,2-dimethyl-6-[7-(2-morpholinoethoxy)quinolin-4-yloxy]benzofuran-3-carboxamide. This invention is pivotal as it encompasses pharmaceutical compositions derived from these forms, and it addresses critical methods for treating disorders such as cancer.
Career Highlights: Currently, Anand is employed at Agouron Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical research. His efforts contribute significantly to the advancement of therapeutic options available for challenging health issues.
Collaborations: Anand has worked alongside talented colleagues such as Yi Li and Jia Liu, fostering an environment of collaboration and innovation. Their combined expertise helps propel significant advancements in their field.
Conclusion: In summary, Anand Sistla stands out as an influential figure in the pharmaceutical industry. His patent and collaborative efforts signify a commitment to developing effective treatments, particularly in the fight against serious diseases like cancer. His contributions reflect the ongoing need for innovative solutions in medicine.